InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
14
T+90 hit rate
50%
T+90 mean return
-3.0%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Klein Matthew B., Directeur et COO. Director active across 2 companies, notably ClearPoint Neuro, Inc.. Cumulatively, 27 filings have been recorded. Breakdown: 0 buy · 14 sells. Total volume traded: €1.5m. History available since 25 June 2021. The latest transaction was disclosed on 21 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations27 total
16,000 shares@ US$11.590.039% mcap100.0% of flowCommon StockSEC:0001193125-26-239431:0
12,417 sharesCommon StockSEC:0001193125-26-234577:0
12,500 shares0Common StockSEC:0001808968-26-000015
12,500 shares0Common StockSEC:0001808968-26-000015:0
21,093 sharesCommon StockSEC:0000950170-25-074448:0
2,804 shares@ US$48.7368.7% of flowCommon StockSEC:0001415889-25-011290:0
3,897 shares@ US$50.09613.5% of flowCommon StockSEC:0001415889-25-005136:0
2,142 shares@ US$45.346.7% of flowCommon StockSEC:0001415889-25-001293:0
70,000 shares0Common StockSEC:0001415889-25-001015:0
8,279 shares@ US$45.1625.9% of flowCommon StockSEC:0001415889-25-000580:0
17,153 sharesCommon StockSEC:0001285550-24-000056:0
3,361 shares@ US$24.8945.7% of flowCommon StockSEC:0001415889-24-011329:0
1,307 shares@ US$25.1352.2% of flowCommon StockSEC:0001415889-24-011247:0
70,000 shares0Common StockSEC:0001415889-24-004106:0
2,237 shares@ US$28.64034.2% of flowCommon StockSEC:0001415889-24-000915:0
10,107 shares@ US$27.148818.1% of flowCommon StockSEC:0001415889-24-000854:0
75,000 shares0Common StockSEC:0001415889-23-016992:0
26,000 shares0Common StockSEC:0001415889-23-006750:0
2,273 shares@ US$42.93296.6% of flowCommon StockSEC:0001415889-23-000879:0
731 shares@ US$41.65622.1% of flowCommon StockSEC:0001415889-23-000836:0
26,000 shares0Common StockSEC:0001415889-23-000689:0
9,269 shares0Common StockSEC:0001420506-22-001135:0
897 shares@ US$42.5150.0006% mcap40.1% of flowCommon StockSEC:0001415889-22-004211:0
775 shares@ US$38.5250.0004% mcap30.0% of flowCommon StockSEC:0001179110-22-000397:0
775 shares@ US$38.5251.9% of flowCommon StockSEC:0001179110-22-000397
25 of 27 declarations
About Klein Matthew B.
Matthew B. Klein is a Director and COO at ClearPoint Neuro, Inc. and PTC THERAPEUTICS, INC. He oversees operations and contributes to the growth strategy of these companies.
